Last reviewed · How we verify

NCT02943161: ALPS

Asthma L-Citrulline Pilot Study

Completed NA Last updated 27 February 2020
What this trial tests

NA trial testing L-Citrulline in Asthma in 41 participants. Completed in 31 March 2019.

Timeline
5 April 2017
Primary endpoint
31 March 2019
31 March 2019

Quick facts

Lead sponsorUniversity of Colorado, Denver
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment41
Start date5 April 2017
Primary completion31 March 2019
Estimated completion31 March 2019
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 18 to 70, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate whether treatment with L-citrulline, which is an amino acid found in some foods, can increase levels of L-arginine and thereby restore the concentration of nitric oxide (NO) in the airways.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Gaps and Future Directions in Clinical Research on Obesity-Related Asthma.
    Hudler AC, Díaz IRR, Sharma S, Holguin F. · · 2023 · cited 5× · PMID 37330948 · DOI 10.1007/s41030-023-00230-2
  2. Obesity: Next game changer of allergic airway diseases?
    Li W, Marx N, Yang Q, Fang D, et al · · 2025 · cited 2× · PMID 40329860 · DOI 10.1002/ctm2.70316

Verify or expand the search:

Other trials of L-Citrulline

Trials testing the same drug.

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02943161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing